$NERV 3 SEC Filings

Filed On	Filing
20 Aug 2026	Form 3: Reilly Joseph H., Chief Operating Officer Holds 20,872 shares of Common Stock
20 Aug 2026	Form 3: Aliquo Anthony, Chief Accounting Officer Holds 1,683 shares of Common Stock
22 Apr 2026	Form 3: O'Connor James Joseph, Chief Business Officer and GC No securities owned
18 Nov 2025	Form 3: Kaul Inderjit, Director No securities owned
07 Jul 2023	Form 3: Boehringer Ingelheim International Gmbh, 10% owner and 1 other Holds 1,275,000 shares of Common Stock
10 Aug 2022	Form 3: Barclays Plc, 10% owner Holds 408,430 shares of Common Stock, $0.0001 par value per share
02 Aug 2018	Form 3: Smith Devin Whittemore, SVP and General Counsel No securities owned
17 Jul 2018	Form 3: Hilleman Jeryl L, Director No securities owned
12 Dec 2017	Form 3: Russell Richard E., President No securities owned
12 Dec 2017	Form 3: Hasler Hans Peter, Director No securities owned
12 Dec 2017	Form 3: Doyle William F, Director No securities owned
05 Sep 2017	Form 3: Saoud Jay, SVP and Head of R&D No securities owned
20 Dec 2016	Form 3: Davidson Michael, Chief Medical Officer Holds 0 shares of Common Stock
03 Nov 2015	Form 3: Kupfer David, Director Holds 0 shares of Common Stock
03 Nov 2015	Form 3: Kupfer David, Director Holds 0 shares of Common Stock
18 May 2015	Form 3: Laghrissi-Thode Fouzia, Director Holds 0 shares of Common Stock
03 Sep 2014	Form 3: Vandervelpen Nico, Director Holds 0 shares of No securities are beneficially owned.
19 Aug 2014	Form 3: Levine Mark S., Vice President,General Counsel No securities owned
17 Jul 2014	Form 3: Johnson & Johnson, 10% owner and 1 other Holds 3,284,353 shares of Common Stock
30 Jun 2014	Form 3: Index Venture Associates Iii Ltd, 10% owner and 3 others Holds 3,436,898 shares of Common Stock

Comments